Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2024

Accounting Policies [Abstract]

Summary of Revenue by Major Source

The following table presents revenue by major source:

	For the Three Months Ended June 30,				For the Six Months Ended June 30,
	2024		2023		2024		2023
Direct to patient	$	5,829,407	$	3,304,113	$	8,059,833	$	5,718,727
Clinical/Medical providers		1,691,360		939,511	$	3,215,323	$	1,971,605
License revenue		—		1,714,920		—		1,714,920
Total revenue from contracts with customers	$	7,520,767	$	5,958,544	$	11,275,156	$	9,405,252

Summary of Potential Common Shares Issuable

Potential dilutive common shares issuable consist of the following at:

	June 30,
	2024		2023
Stock options		23,629		26,138
Restricted stock units		1,275,862		1,608,615
Other warrants		668,250		668,250
Total		1,967,741		2,303,003